Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)-Reference-Cited by-同舟云学术

Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Published:2021-11-16 Issue: Volume: Page:
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Tonello Marco,Baratti Dario,Sammartino Paolo,Di Giorgio Andrea,Robella Manuela,Sassaroli Cinzia,Framarini Massimo,Valle Mario,Macrì Antonio,Graziosi Luigina,Coccolini Federico,Lippolis Piero Vincenzo,Roberta Gelmini,Deraco Marcello,Biacchi Daniele,Santullo Francesco,Vaira Marco,Di Lauro Katia,D’Acapito Fabrizio,Carboni Fabio,Giuffrè Giuseppe,Donini Annibale,Fugazzola Paola,Faviana Pinuccia,Lorena Sorrentino,Scapinello Antonio,Del Bianco Paola,Sommariva Antonio

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-021-11045-3.pdf

Reference82 articles.

1. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–53.

2. Franko J, Shi Q, Goldman CD, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263–7.

3. Quere P, Facy O, Manfredi S, Jooste V, Faivre J, Lepage C, et al. Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: a population-based study. Dis Colon Rectum. 2015;58:743–52.

4. Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17:1709–19.

5. Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89:1545–50.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis;European Journal of Surgical Oncology;2024-09

2. Microsatellite instability should not determine candidacy for cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion in patients with peritoneal metastases from colorectal cancer;Journal of Gastrointestinal Surgery;2024-09

3. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Cancer with Peritoneal Metastasis: A Single-Center Cohort Study;Medicina;2024-06-27

4. Top Peritoneal Surface Malignancy Articles from 2022 to Inform your Cancer Practice;Annals of Surgical Oncology;2024-05-03

5. The Crucial Value of Glutathione Peroxidase 2 to Understand the ‘Two-Faced’ Role of Reactive Oxygen Species in Lung Adenocarcinoma;Annals of Surgical Oncology;2024-05-03